Atrial-selective sodium channel block as a novel strategy for the management of atrial fibrillation.
about
Advances in the Pharmacological Treatment of Atrial Fibrillation.Electrophysiologic basis for the antiarrhythmic actions of ranolazine.Mechanisms of atrial-selective block of Na⁺ channels by ranolazine: I. Experimental analysis of the use-dependent blockMechanisms of atrial-selective block of Na⁺ channels by ranolazine: II. Insights from a mathematical modelNovel pharmacological targets for the rhythm control management of atrial fibrillation.Comparison of electrophysiological and antiarrhythmic effects of vernakalant, ranolazine, and sotalol in canine pulmonary vein sleeve preparations.Targeting atrioventricular differences in ion channel properties for terminating acute atrial fibrillation in pigs.The Use of Ranolazine in the Management of Recurrent Atrial Fibrillation After Percutaneous Radiofrequency AblationNew developments in atrial antiarrhythmic drug therapy.Ranolazine: an anti-anginal drug with further therapeutic potential.The pharmaceutical pipeline for atrial fibrillation.Individualized therapy in patients with atrial fibrillation: new look at atrial fibrillation.Vernakalant hydrochloride to treat atrial fibrillation.Cardiac potassium channel subtypes: new roles in repolarization and arrhythmia.Role of Calcium-activated Potassium Channels in Atrial Fibrillation Pathophysiology and Therapy.Effects of Amiodarone and N-desethylamiodarone on Cardiac Voltage-Gated Sodium Channels.Atrial-selective inhibition of sodium-channel current by Wenxin Keli is effective in suppressing atrial fibrillation.Larger late sodium current density as well as greater sensitivities to ATX II and ranolazine in rabbit left atrial than left ventricular myocytes.Synergistic Anti-arrhythmic Effects in Human Atria with Combined Use of Sodium Blockers and Acacetin.Cardiac Potassium Channels: Physiological Insights for Targeted Therapy.[New developments in the antiarrhythmic therapy of atrial fibrillation].
P2860
Q34383573-5BFDF8ED-4D16-4D9D-BB19-929018855EA8Q35091243-8CD50BB3-1C9D-4182-805E-E2D878607831Q35395995-0DEB691A-157F-4443-A98A-2625B990747FQ35396014-6A72B49A-50AF-4073-9AE7-BC738FFD69C2Q35489060-D8F068BE-207D-4F5B-86B1-089181AD254DQ35785780-55F86200-D01D-433F-AB44-309A3C0DBBD5Q35835645-2CDC63A4-B538-4614-8538-4BFF062A2631Q37496011-7B788DF8-05B1-455D-AE1A-C603A6499914Q37697498-08BB4700-31C9-469A-86A2-3865A54163A6Q37707393-29641B19-0721-415D-81BC-66A9534D3482Q37821928-A86038E1-79A9-42A4-A411-73B152EEB219Q38056112-987FC88D-5198-4E47-AD01-933B3FFC68ADQ38195102-2F7323D8-A127-4212-8258-DF6DD9673840Q38201409-DEB6164E-DD94-4DBB-A48C-B7EDB43D6DFCQ38399159-71BBE295-4525-4552-92F7-27E5E3BAC69CQ38684842-434B98C7-CD79-45F0-8B74-DAB598EC10FCQ39760319-94CA84E7-0255-4418-8261-9E5EAC83806CQ44447235-B3158F62-F2A2-4ABE-88BF-2EA5F7780868Q47161197-8A1E2858-365B-47D2-880F-AE617FA62987Q48293093-AB1644F0-6D84-423E-A7F3-B78C814FEE4BQ50690847-9AD493DA-265F-4AED-875F-32338789A771
P2860
Atrial-selective sodium channel block as a novel strategy for the management of atrial fibrillation.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 20 August 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Atrial-selective sodium channe ...... gement of atrial fibrillation.
@en
Atrial-selective sodium channe ...... gement of atrial fibrillation.
@nl
type
label
Atrial-selective sodium channe ...... gement of atrial fibrillation.
@en
Atrial-selective sodium channe ...... gement of atrial fibrillation.
@nl
prefLabel
Atrial-selective sodium channe ...... gement of atrial fibrillation.
@en
Atrial-selective sodium channe ...... gement of atrial fibrillation.
@nl
P2860
P1476
Atrial-selective sodium channe ...... gement of atrial fibrillation.
@en
P2093
Alexander Burashnikov
P2860
P304
P356
10.1016/J.JELECTROCARD.2009.07.007
P577
2009-08-20T00:00:00Z